Clinical journal of the American Society of Nephrology : CJASN | 2019
Are Generic Immunosuppressive Drugs the Solution for Providing Lifelong Medication Coverage to Transplant Recipients?
Abstract
Achieving lifelong coverage for immunosuppressive drugs through the Medicare Part B benefit has long been a need for the kidney transplant community. A kidney transplant recipient’s Medicare eligibility terminates 3 years post-transplant unless the patient meets alternate criteria for ongoing